Atea Pharmaceuticals, Inc. (AVIR) vs Orchestra BioMed Holdings, Inc. (OBIO)
- Atea Pharmaceuticals, Inc. AVIR 4.32 −4.64%
- Orchestra BioMed Holdings, Inc. OBIO 5.45 −5.05%
Atea Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Atea Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($363.3M and $345.0M). Atea Pharmaceuticals, Inc. has the higher net margin (0.00% vs −186.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Atea Pharmaceuticals, Inc. leads on 10 and Orchestra BioMed Holdings, Inc. on 5.
Valuation
Profitability
| Metric | AVIR | OBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 99.51% | 65.16% |
| Operating margin | 0.00% | (181.36%) | 0.00% |
| Net margin | 0.00% | (186.30%) | 0.00% |
| Free cash flow margin | 0.00% | (184.83%) | 0.00% |
| Return on equity | (58.14%) | (607.32%) | (56.36%) |
| Return on assets | (52.99%) | (75.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack